HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Medivir AB (STO:MVIRB) today announces that a Capital Markets Meeting will be arranged for investors, analysts and journalists on Thursday 26 March at 2pm - 4.30pm CEST, in Stockholm.
CEO Niklas Prager and members of the Management team will present the company’s operations and give an update about our pharmaceuticals and R&D projects.
Help employers find you! Check out all the jobs and post your resume.
Medivir AB (STO:MVIRB) today announces that a Capital Markets Meeting will be arranged for investors, analysts and journalists on Thursday 26 March at 2pm - 4.30pm CEST, in Stockholm.
CEO Niklas Prager and members of the Management team will present the company’s operations and give an update about our pharmaceuticals and R&D projects.
Help employers find you! Check out all the jobs and post your resume.
